TRIESENCE Drug Patent Profile

✉ Email this page to a colleague

When do Triesence patents expire, and when can generic versions of Triesence launch?

Triesence is a drug marketed by Harrow Eye and is included in one NDA. There are two patents protecting this drug.

This drug has twenty-five patent family members in twenty-one countries.

The generic ingredient in TRIESENCE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Triesence

A generic version of TRIESENCE was approved as triamcinolone acetonide by TARO on October 1^st, 1986.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for TRIESENCE?
What are the global sales for TRIESENCE?
What is Average Wholesale Price for TRIESENCE?

Summary for TRIESENCE

International Patents:	25
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	82
Clinical Trials:	10
Patent Applications:	4,291
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for TRIESENCE
What excipients (inactive ingredients) are in TRIESENCE?	TRIESENCE excipients list
DailyMed Link:	TRIESENCE at DailyMed

Drug patent expirations by year for TRIESENCE

Recent Clinical Trials for TRIESENCE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Oxular Limited	Phase 2
Wake Forest University Health Sciences	Phase 4
Bausch & Lomb Incorporated	N/A

See all TRIESENCE clinical trials

Pharmacology for TRIESENCE

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

US Patents and Regulatory Information for TRIESENCE

TRIESENCE is protected by three US patents.

Patents protecting TRIESENCE

Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: VISUALIZATION DURING VITRECTOMY PROCEDURES

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Harrow Eye	TRIESENCE	triamcinolone acetonide	INJECTABLE;INTRAVITREAL	022048-001	Nov 29, 2007		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Harrow Eye	TRIESENCE	triamcinolone acetonide	INJECTABLE;INTRAVITREAL	022048-001	Nov 29, 2007		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TRIESENCE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Harrow Eye	TRIESENCE	triamcinolone acetonide	INJECTABLE;INTRAVITREAL	022048-001	Nov 29, 2007	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for TRIESENCE

See the table below for patents covering TRIESENCE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Australia	2009223649	Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection	⤷ Sign Up
Japan	5581227		⤷ Sign Up
Canada	2717605	SUSPENSIONS D'ACETONIDE DE TRIAMCINOLONE TRES FLOCULEES ET DE FAIBLE VISCOSITE POUR INJECTION INTRAVITREENNE (LOW VISCOSITY, HIGHLY FLOCCULATED TRIAMCINOLONE ACETONIDE SUSPENSIONS FOR INTRAVITREAL INJECTION)	⤷ Sign Up
South Korea	101555293		⤷ Sign Up
Russian Federation	2481842	НИЗКОВЯЗКИЕ ВЫСОКОФЛОКУЛИРОВАННЫЕ СУСПЕНЗИИ ТРИАМЦИНОЛОНА АЦЕТОНИДА ДЛЯ ИНТРАВИТРЕАЛЬНЫХ ИНЪЕКЦИЙ (LOW-VISCOUS HIGHLY FLOCCULATED TRIAMCINOLONE ACETONIDE SUSPENSIONS FOR INTRAVITREAL INJECTIONS)	⤷ Sign Up
Argentina	070824	SUSPENSIONES PARA INYECCION INTRAVITREA DE TRIAMCINOLONA ACETONIDO DE BAJA VISCOSIDAD, ALTAMENTE FLOCULADAS	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration